GB1563311A - Pharmaceutical composition of insulin for rectal use - Google Patents

Pharmaceutical composition of insulin for rectal use Download PDF

Info

Publication number
GB1563311A
GB1563311A GB38069/76A GB3806976A GB1563311A GB 1563311 A GB1563311 A GB 1563311A GB 38069/76 A GB38069/76 A GB 38069/76A GB 3806976 A GB3806976 A GB 3806976A GB 1563311 A GB1563311 A GB 1563311A
Authority
GB
United Kingdom
Prior art keywords
insulin
poe
pharmaceutical composition
ether
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB38069/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50116028A external-priority patent/JPS5241210A/ja
Priority claimed from JP50117810A external-priority patent/JPS5244222A/ja
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of GB1563311A publication Critical patent/GB1563311A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
GB38069/76A 1975-09-26 1976-09-14 Pharmaceutical composition of insulin for rectal use Expired GB1563311A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP50116028A JPS5241210A (en) 1975-09-26 1975-09-26 Method of making insulin preparations for rectal administration
JP50117810A JPS5244222A (en) 1975-09-30 1975-09-30 Method of making insulin preparations for rectal application

Publications (1)

Publication Number Publication Date
GB1563311A true GB1563311A (en) 1980-03-26

Family

ID=26454417

Family Applications (1)

Application Number Title Priority Date Filing Date
GB38069/76A Expired GB1563311A (en) 1975-09-26 1976-09-14 Pharmaceutical composition of insulin for rectal use

Country Status (8)

Country Link
AT (1) AT344327B (enExample)
CA (1) CA1050426A (enExample)
DE (1) DE2641819A1 (enExample)
DK (1) DK431876A (enExample)
FR (1) FR2325386A1 (enExample)
GB (1) GB1563311A (enExample)
NO (1) NO146044C (enExample)
SE (1) SE7610595L (enExample)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3210194A1 (de) * 1981-07-14 1983-02-03 Vsesojuznyj Kardiologičeskij naučnyj centr Akademii Medicinskich Nauk SSSR, Moskva Arzneimittel zur behandlung von diabetes mellitus
US4434159A (en) 1980-03-31 1984-02-28 Teijin Limited Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
GB2161380A (en) * 1984-07-13 1986-01-15 Nat Res Dev Pharmaceutical antifungal composition
EP0129582A4 (en) * 1982-12-23 1987-09-02 Research Corp BIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS FOR ORAL ADMINISTRATION.
US4760059A (en) * 1985-08-05 1988-07-26 Hoffmann-La Roche Inc. Rectal dosage form
US4783441A (en) * 1979-04-30 1988-11-08 Hoechst Aktiengesellschaft Aqueous protein solutions stable to denaturation
EP1401406A2 (en) * 2001-07-02 2004-03-31 Merrion Research I Limited Delivery of a bioactive material
CN102183632A (zh) * 2010-01-18 2011-09-14 精工爱普生株式会社 喷出用液体、生物试样的喷出方法及化合物
US8530412B2 (en) 2005-03-30 2013-09-10 Canon Kabushiki Kaisha Ejection liquid, ejection method, method of making droplets from liquid, cartridge and ejection device

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6042766B2 (ja) * 1978-12-09 1985-09-25 日本化薬株式会社 基剤
EP0018609B1 (de) * 1979-04-30 1983-09-21 Hoechst Aktiengesellschaft Gegen Denaturierung beständige, wässrige Protein-Lösungen, Verfahren zu ihrer Herstellung und ihre Verwendung
DE2917535C2 (de) * 1979-04-30 1986-10-30 Hoechst Ag, 6230 Frankfurt Gegen Denaturierung beständige Insulinlösungen
JPS58501125A (ja) * 1981-07-17 1983-07-14 ノルデイスク・インスリンラボラトリウム 安定な水性治療性インシユリン製剤及びその製造方法
DE3443877A1 (de) * 1984-06-09 1985-12-12 Hoechst Ag Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung
JPH0651637B2 (ja) 1985-03-28 1994-07-06 エーザイ株式会社 ペプタイドの吸着防止組成物

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783441A (en) * 1979-04-30 1988-11-08 Hoechst Aktiengesellschaft Aqueous protein solutions stable to denaturation
US4434159A (en) 1980-03-31 1984-02-28 Teijin Limited Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
DE3210194A1 (de) * 1981-07-14 1983-02-03 Vsesojuznyj Kardiologičeskij naučnyj centr Akademii Medicinskich Nauk SSSR, Moskva Arzneimittel zur behandlung von diabetes mellitus
EP0129582A4 (en) * 1982-12-23 1987-09-02 Research Corp BIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS FOR ORAL ADMINISTRATION.
US4681876A (en) * 1984-07-13 1987-07-21 National Research Development Corporation Antifungal utility of bile acids
GB2161380A (en) * 1984-07-13 1986-01-15 Nat Res Dev Pharmaceutical antifungal composition
US4760059A (en) * 1985-08-05 1988-07-26 Hoffmann-La Roche Inc. Rectal dosage form
EP1401406A2 (en) * 2001-07-02 2004-03-31 Merrion Research I Limited Delivery of a bioactive material
US8753683B2 (en) 2001-07-02 2014-06-17 Merrion Research Iii Limited Delivery of a bioactive material
US8530412B2 (en) 2005-03-30 2013-09-10 Canon Kabushiki Kaisha Ejection liquid, ejection method, method of making droplets from liquid, cartridge and ejection device
CN102183632A (zh) * 2010-01-18 2011-09-14 精工爱普生株式会社 喷出用液体、生物试样的喷出方法及化合物
EP2357007A3 (en) * 2010-01-18 2013-02-27 Seiko Epson Corporation Liquid for discharge, method for discharging biospecimen, and compound
CN102183632B (zh) * 2010-01-18 2015-04-29 精工爱普生株式会社 喷出用液体、生物试样的喷出方法及化合物

Also Published As

Publication number Publication date
ATA713376A (de) 1977-11-15
NO146044C (no) 1982-08-04
NO763296L (enExample) 1977-03-29
CA1050426A (en) 1979-03-13
FR2325386A1 (fr) 1977-04-22
DK431876A (da) 1977-03-27
AT344327B (de) 1978-07-10
SE7610595L (sv) 1977-03-27
DE2641819A1 (de) 1977-04-07
FR2325386B1 (enExample) 1979-01-12
NO146044B (no) 1982-04-13

Similar Documents

Publication Publication Date Title
GB1563311A (en) Pharmaceutical composition of insulin for rectal use
US4154820A (en) Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
KR100187316B1 (ko) 저에스트로겐 경구 피임제
CA2018818C (en) Treatment of postmenopausal disorders
FI110307B (fi) Estrogeeni/progestiini/antiprogestiinia sisältävä ehkäisyvalmiste ja pakkaus
US4315925A (en) Method of administering natural female sex hormones
EP0799043B1 (en) Cyclophasic hormonal regimen containing antiprogestin and progestin
EP1310257A2 (de) Kombination zur hormonalen Kontrazeption
JP4023820B2 (ja) エストラ−１，３，５（１０）−トリエン誘導体を含有する医薬製剤
US20050282790A1 (en) Therapeutic gestagens for the treatment of premenstrual dysphoric disorder
DE102005034498A1 (de) Orale Kontrazeption mit Trimegeston
HU203046B (en) Process for producing ophtalmological compositions containing cyclosporin
NL192206C (nl) Werkwijze voor het bereiden van een 13ß-alkyl-17Ó-ethynyl-17ß- alkanoyloxy-gon-4-en-3-on-oxim verbinding, werkwijze voor het bereiden van farmaceutische preparaten met een dergelijke verbinding alsmede de gevormde farmaceutische preparaten.
JONES Effects of testosterone, testosterone metabolites and anti-androgens on the function of the male accessory glands in the rabbit and rat
US5891867A (en) Hormonal medicaments and their use for the correction of oestrogenic deficiencies
DE60003943T2 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
EP0001851B1 (en) Highly concentrated pharmaceutical formulations of steroids and processes for their preparation
IE48133B1 (en) A sold stable pharmaceutical composition based on 17 -ethynyl-1,3-dibenzoyloxy-7 -methyl-1,3,5(10)-oestratien-17 -ol
US2890152A (en) Topical anti-inflammatory compositions
DE3339295C2 (enExample)
Scublinsky et al. THE CONTRACEPTIVE ACTION OF IMPEDING OESTROGENS
US3228837A (en) Oral anabolic composition and method of use
US3284303A (en) Orally active progesterone compositions
GB1569286A (en) Oily depot solutions of gestagents for intramuscular injection
Vermeulen Longacting steroid preparations

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee